LYRA
NASDAQ · Pharmaceuticals
Lyra Therapeutics Inc
$0.40
-0.08 (-15.79%)
Open$0.45
Previous Close$0.48
Day High$0.45
Day Low$0.11
52W High$8.75
52W Low—
Volume—
Avg Volume8.7K
Market Cap603.5K
P/E Ratio—
EPS$-19.31
SectorPharmaceuticals
Analyst Ratings
Strong Sell
6 analysts
Price Target
+3,400.0% upside
Current
$0.40
$0.40
Target
$14.00
$14.00
$9.32
$14.00 avg
$16.42
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 386.5K | 582.2K | 681.7K |
| Net Income | -28,084,575 | -38,072,175 | 169.3K |
| Profit Margin | -7,266.1% | -6,902.8% | 24.8% |
| EBITDA | -29,681,180 | -42,471,940 | 337.6K |
| Free Cash Flow | — | — | 110.0K |
| Rev Growth | -33.6% | -33.6% | +3.7% |
| Debt/Equity | — | — | 0.67 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |